|
1
|
Li J, He X, Dong R, Wang Y, Yu J and Qiu
H: Frequent loss of NISCH promotes tumor proliferation and invasion
in ovarian cancer via inhibiting the FAK signal pathway. Mol Cancer
Ther. 14:1202–1212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baranwal S, Wang Y, Rathinam R, Lee J, Jin
L, McGoey R, Pylayeva Y, Giancotti F, Blobe GC and Alahari SK:
Molecular characterization of the tumor-suppressive function of
nischarin in breast cancer. J Natl Cancer Inst. 103:1513–1528.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen J, Feng WL, Mo WJ, Ding XW and Xie
SN: Expression of integrin-binding protein nischarin in metastatic
breast cancer. Mol Med Rep. 12:77–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang C, Wei W, Han D, Meng J, Zhu F, Xiao
Y, Wu G1, Shi X and Zhang L: Expression of nischarin negatively
correlates with estrogen receptor and alters apoptosis, migration
and invasion in human breast cancer. Biochem Biophys Res Commun.
484:536–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alahari SK, Lee JW and Juliano RL:
Nischarin, a novel protein that interacts with the integrin α5
subunit and inhibits cell migration. J Cell Bio. 151:1141–1154.
2000. View Article : Google Scholar
|
|
6
|
Maziveyi M and Alahari SK: Breast cancer
tumor suppressors: A special emphasis on novel protein nischarin.
Cancer Res. 75:4252–4259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding Y, Zhang R, Zhang K, Lv X, Chen Y, Li
A, Wang L, Zhang X and Xia Q: Nischarin is differentially expressed
in rat brain and regulates neuronal migration. PLoS One.
8:e545632013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kõks S, Luuk H, Nelovkov A, Areda T and
Vasar E: A screen for genes induced in the amygdaloid area during
cat odor exposure. Genes Brain Behav. 3:80–89. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Keller B, Mestre-Pinto JI,
Álvaro-Bartolomé M, Martinez- Sanvisens D, Farre M, García-Fuster
MJ, García-Sevilla JA and Torrens M; NEURODEP Group, : A biomarker
to differentiate between primary and cocaine-induced major
depression in cocaine use disorder: The role of platelet
IRAS/nischarin (I1-Imidazoline Receptor). Front Psychiatry.
8:2582017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J and Abdel-Rahman AA: Inhibition of
nischarin expression attenuates rilmenidine-evoked hypotension and
phosphorylated extracellular signal-regulated kinase 1/2 production
in the rostral ventrolateral medulla of rats. J Pharmacol Exp Ther.
324:72–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu X, Xu W, Cui G, Yan Y, Wu X, Li L, Tan
X, Wu Q and Gu X: The expression pattern of Nischarin after
lipopolysaccharides (LPS)-induced neuroinflammation in rats brain
cortex. Inflamm Res. 62:929–940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alahari SK: Nischarin inhibits Rac induced
migration and invasion of epithelial cells by affecting signaling
cascades involving PAK. Exp Cell Res. 288:415–424. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alahari SK, Reddig PJ and Juliano RL: The
integrin-binding protein nischarin regulates cell migration by
inhibiting PAK. EMBO J. 23:2777–2788. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding Y, Milosavljevic T and Alahari SK:
Nischarin inhibits LIM kinase to regulate cofilin phosphorylation
and cell invasion. Mol Cell Biol. 28:3742–3756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Reddig PJ, Xu D and Juliano RL: Regulation
of p21-activated kinase-independent Rac1 signal transduction by
nischarin. J Biol Chem. 280:30994–31002. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jain P, Baranwal S, Dong S, Struckhoff AP,
Worthylake RA and Alahari SK: Integrin-Binding protein nischarin
interacts with tumor suppressor liver kinase B1 (LKB1) to regulate
cell migration of breast epithelial cells. J Biol Chem.
288:15495–15509. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maziveyi M, Dong S, Baranwal S and Alahari
SK: Nischarin regulates focal adhesion and Invadopodia formation in
breast cancer cells. Mol Cancer. 17:212018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maziveyi M, Dong S, Baranwal S, Mehrnezhad
A, Rathinam R, Huckaba TM, Mercante DE, Park K and Alahari SK:
Exosomes from nischarin-expressing cells reduce breast cancer cell
motility and tumor growth. Cancer Res. 79:2152–2166. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Altevogt P, Doberstein K and Fogel M:
L1CAM in human cancer. Int J Cancer. 138:1565–1576. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sökeland G and Schumacher U: The
functional role of integrins during intra- and extravasation within
the metastatic cascade. Mol Cancer. 18:122019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Montgomery AM, Becker JC, Siu CH, Lemmon
VP, Cheresh DA, Pancook JD, Zhao X and Reisfeld RA: Human neural
cell adhesion molecule L1 and rat homologue NILE are ligands for
integrin alpha v beta 3. J Cell Biol. 132:475–485. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ruppert M, Aigner S, Hubbe M, Yagita H and
Altevogt P: The L1 adhesion molecule is a cellular ligand for
VLA-5. J Cell Biol. 131:1881–1891. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alahari SK and Nasrallah H: A membrane
proximal region of the integrin alpha5 subunit is important for its
interaction with nischarin. Biochem J. 377:449–457. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grela E, Kozłowska J and Grabowiecka A:
Current methodology of MTT assay in bacteria-A review. Acta
Histochem. 120:303–311. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guzmán C, Bagga M, Kaur A, Westermarck J
and Abankwa D: ColonyArea: An imageJ plugin to automatically
quantify colony formation in clonogenic assays. PLoS One.
9:e924442014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Justus CR, Leffler N, Ruiz-Echevarria M
and Yang LV: In vitro cell migration and invasion assays. J Vis
Exp. 88:e510462014.
|
|
27
|
Liu Q, Li X, Bao YS, Lu J, Li H, Huang Z
and Liu F: Chemical synthesis and functional characterization of a
new class of ceramide analogues as anti-cancer agents. Bioorg Med
Chem. 27:1489–1496. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun JG, Ruan F, Zeng XL, Xiang J, Li X, Wu
P, Fung KP and Liu FY: Clitocine potentiates TRAIL-mediated
apoptosis in human colon cancer cells by promoting mcl-1
degradation. Apoptosis. 21:1144–1157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Lima JF, Nofech-Mozes S, Bayani J and
Bartlett JM: EMT in breast carcinoma-a review. J Clin Med.
5:652016. View Article : Google Scholar
|
|
31
|
Bouris P, Skandalis SS, Piperigkou Z,
Afratis N, Karamanou K, Aletras AJ, Moustakas A, Theocharis AD and
Karamanos NK: Estrogen receptor alpha mediates epithelial to
mesenchymal transition, expression of specific matrix effectors and
functional properties of breast cancer cells. Matrix Biol.
43:42–60. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cichon MA, Nelson CM and Radisky DC:
Regulation of epithelial-mesenchymal transition in breast cancer
cells by cell contact and adhesion. Cancer Inform. 14:1–13.
2015.PubMed/NCBI
|
|
34
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gregoire JM, Fleury L, Salazar-Cardozo C,
Alby F, Masson V, Arimondo PB and Ausseil F: Identification of
epigenetic factors regulating the mesenchyme to epithelium
transition by RNA interference screening in breast cancer cells.
BMC Cancer. 16:7002016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zañudo JM, Guinn MT, Farquhar K, Szenk M,
Steinway SN, Balázsi G and Albert R: Towards control of cellular
decision-making networks in the epithelial-to-mesenchymal
transition. Phys Biol. 16:0310022019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mrozik KM, Blaschuk OW, Cheong CM,
Zannettino AC and Vandyke K: N-Cadherin in cancer metastasis, its
emerging role in haematological malignancies and potential as a
therapeutic target in cancer. BMC Cancer. 18:9392018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Olea-Flores M, Juárez-Cruz JC,
Mendoza-Catalán MA, Padilla-Benavides T and Navarro-Tito N:
Signaling pathways induced by leptin during epithelial–mesenchymal
transition in breast cancer. Int J Mol Sci. 19:34932018. View Article : Google Scholar
|
|
41
|
Olea-Flores M, Zuñiga-Eulogio MD,
Mendoza-Catalán MA, Rodríguez-Ruiz HA, Castañeda-Saucedo E,
Ortuño-Pineda C, Padilla-Benavides T and Navarro-Tito N:
Extracellular-Signal regulated kinase: A central molecule driving
epithelial- mesenchymal transition in cancer. Int J Mol Sci.
20:28852019. View Article : Google Scholar
|
